IDO1 and acute myeloid leukemia: Indeed, it has been demonstrated that chemotherapy-treated dying AML cells release ATP, which in turn up-regulates IDO1 expression in DCs, favors the induction of Tregs and contributes to creating an immune suppressive microenvironment in AML [208].